TITLE

Genentech reports positive 2-year results for phase 3 study of ranibizumab in DME

PUB. DATE
March 2011
SOURCE
Ocular Surgery News;3/25/2011, Vol. 29 Issue 6, p58
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the phase 3 RISE study which shows that ranibizumab improves the visual acuity of patients with diabetic macular edema.
ACCESSION #
86439115

 

Related Articles

  • University of Utah, Allergan collaborate on target-based clinical research. Hasson, Matt // Ocular Surgery News;4/25/2014, Vol. 32 Issue 8, p48 

    The article discusses the collaboration between Voyant Biotherapeutics of University of Utah's John A. Moran Eye Center and pharmaceutical company Allergan on research and development of disease-associated pathways, targets, and new therapeutic agents for age-related macular degeneration (AMD) ....

  • FDA actions. Elliott, William T. // Primary Care Reports;Aug2011 Pharmacology Watch, p2 

    The article reports on the approval granted by the U.S. Food and Drug Administration (FDA) to the first generic version of levofloxacin and an abuse-resistant short-acting oxycodone tablet called the AVERSION Technology from Acura Pharmaceuticals.

  • Compounded Avastin Recall Good News for Regeneron. Serebrov, Mari // BioWorld Today;3/21/2013, Vol. 24 Issue 54, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) has called for a recall of the cancer drug Avastin from Genentech Inc. for its off-label use in treating wet age-related macular degeneration (AMD). The recall caused Regeneron to take advantage of the cancer drug market with...

  • Eye infections prompt bevacizumab recall. Webb, Jennifer A. // Ophthalmology Times;4/15/2013, Vol. 38 Issue 8, p6 

    The article reports on the announcement of U.S. Food and Drugs on March 18, 2013 that lots of bevacizumab have been recalled by the compounding pharmacy Clinical Specialties in Martinez, Georgia due to its linkage to cases of endophthalmitis. It says that the recall prompted the drug...

  • Detection of aac(6′)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. Chmelnitsky, Inna; Hermesh, Orit; Navon-Venezia, Shiri; Strahilevitz, Jacob; Carmeli, Yehuda // Journal of Antimicrobial Chemotherapy (JAC);Oct2009, Vol. 64 Issue 4, p718 

    Objectives: We aimed to evaluate the occurrence and characteristics of plasmid-mediated quinolone resistance (PMQR) genes in KPC-producing (KPC-P) Klebsiella pneumoniae (Kpn) isolates in Tel Aviv Medical Center, Israel.

  • Rectal swab testing before prostate biopsy: experience in a VA Medical Center urology practice. Cook, I; Angel, J B; Vera, P L; Demos, J; Preston, D // Prostate Cancer & Prostatic Diseases;Dec2015, Vol. 18 Issue 4, p365 

    Background:Infectious complications following transrectal ultrasound prostate biopsy (TRUSBx) have been increasing. Pre-biopsy prophylaxis with fluoroquinolone (FQL) antibiotics is a recommended and accepted practice. Increasing emergence of FQL-resistant bacteria is believed to be related to...

  • FDA clears trials on embryonic stem cells to treat Stargardt's macular dystrophy, dry AMD. Hasson, Matt; Mickunas, Edmund // Ocular Surgery News;3/10/2011, Vol. 29 Issue 5, p24 

    The article reports on the U.S. Food and Drug Administration's approval for clinical trials using embryonic stem cells for the treatment of dry age-related macular degeneration (AMD) and Stargardt's macular dystrophy. It notes the ability of retinal pigment epithelial (RPE) cells, which are...

  • FDA Briefs.  // Ophthalmology Times;3/1/2002, Vol. 27 Issue 5, p4 

    Presents news briefs on drugs in the United States as of March 1, 2002. Strength of brimonidine tartrate from Allergan suited for pediatric patients over two years old for treating intraocular pressure; Clearance given by the U.S. Food and Drug Administration for the marketing of a capsular...

  • Topical gel controls surgical bleeding. Garrett, Anna D. // Drug Topics;Dec2011, Vol. 155 Issue 12, p50 

    The article offers news briefs related to anticoagulation therapies as of December 2011. The U.S. Food & Drug Administration (FDA) has approved the use of the gel LeGoo by surgeons to temporarily stop blood during vascular surgery. A European study suggests that frequent use of aspirin can lead...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics